Stonepine Capital Management, LLC 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 3:29 pm Sale |
2021-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 0 0.000% |
-27,975,520 (Position Closed) |
Filing |
| 2021-02-12 4:57 pm Purchase |
2020-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 27,975,520 8.100% |
1,308,840 (+4.91%) |
Filing |
| 2020-12-16 6:02 pm Purchase |
2020-12-11 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 26,666,680 7.700% |
26,666,680 (New Position) |
Filing |